There are also numerous changes that occur in the cancer cell’s apoptotic threshold that, overall, work to prevent apoptosis; additionally, most members of the BCL-2 family exhibit changed expression patterns in colorectal carcinoma tumors, having a significant impact on both cancer progression and therapy resistance [15]. This evidence concerns the gene BCL2 and colorectal carcinoma.